
News|Articles|December 16, 2025
A look into the volume of Quest lab data for colorectal cancer research
Author(s)Quest Diagnostics
This datasheet illustrates how Quest Diagnostics' extensive de-identified lab data can be leveraged to accelerate and optimize clinical trials for colorectal cancer research. Researchers can use this real-world data to identify high concentrations of eligible patients, select optimal trial sites, find suitable principal investigators, and drive targeted patient recruitment efforts.
Trending on Applied Clinical Trials Online
1
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
2
From Participation to Understanding: Reframing Engagement in Clinical Trials
3
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
4
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
5